Tumor Immunology _ Multidisciplinary Science Driving Combination Therapy

New knowledge in the field of cancer immunotherapy combined with new technologies has given birth to the next generation of vaccines, adoptive cellular therapies, and T cell modulating agents, all of which are being investigated in preclinical models and in patients. This conference brings together experts from academia and industry, who have pioneered these areas of immunologic science, and will showcase the integration of this increasingly complicated knowledge being uncovered in this field of research into rapid translation into clinical applications.
+ show speakers and program
basic mechanisms, cancer, tumor immunology

8 Feb - 13 Feb 2015
meeting website